glp 1 gip triple agonist Hitting the G Spot: The New Triple G for Weight Loss Retatrutide: How the Triple Agonist

Sean Hashmi, MD Medical Reviewer Sean Hashmi, MD, is an experienced nephrologist and obesity medicine specialist based in Southern California

Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review

However, emerging lawsuits claim the drug caused an eye condition called non-arteritic anterior ischemic optic neuropathy NAION

This divergent evidence may be due to the different experimental conditions of the studies

Potential sleep disturbances and bone pain in some individuals

However, without direct head-to-head comparisons, treatment decisions rely on indirect evidence from heterogeneous trial populations, leaving optimal treatment choices uncertain